<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2020-10-07" version="236">
<accession>P07814</accession>
<accession>A0AVA9</accession>
<accession>B9EGH3</accession>
<accession>Q05BP6</accession>
<accession>Q05DF8</accession>
<accession>Q5DSM1</accession>
<accession>Q5H9S5</accession>
<accession>Q6PD57</accession>
<accession>Q86X73</accession>
<name>SYEP_HUMAN</name>
<protein>
<recommendedName>
<fullName>Bifunctional glutamate/proline--tRNA ligase</fullName>
</recommendedName>
<alternativeName>
<fullName>Bifunctional aminoacyl-tRNA synthetase</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell proliferation-inducing gene 32 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Glutamatyl-prolyl-tRNA synthetase</fullName>
</alternativeName>
<domain>
<recommendedName>
<fullName>Glutamate--tRNA ligase</fullName>
<ecNumber>6.1.1.17</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Glutamyl-tRNA synthetase</fullName>
<shortName>GluRS</shortName>
</alternativeName>
</domain>
<domain>
<recommendedName>
<fullName>Proline--tRNA ligase</fullName>
<ecNumber evidence="35 36">6.1.1.15</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Prolyl-tRNA synthetase</fullName>
</alternativeName>
</domain>
</protein>
<gene>
<name type="primary" evidence="46">EPRS1</name>
<name type="synonym">EPRS</name>
<name type="synonym">GLNS</name>
<name type="synonym">PARS</name>
<name type="synonym">QARS</name>
<name type="synonym">QPRS</name>
<name type="ORF">PIG32</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS GLU-308 AND VAL-1043</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT GLU-308</scope>
<source>
<tissue>Brain</tissue>
<tissue>Duodenum</tissue>
<tissue>Eye</tissue>
<tissue>Lung</tissue>
<tissue>Placenta</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="1448" last="1455">
<title>The primary structure of human glutaminyl-tRNA synthetase. A highly conserved core, amino acid repeat regions, and homologies with translation elongation factors.</title>
<authorList>
<person name="Fett R."/>
<person name="Knippers R."/>
</authorList>
<dbReference type="PubMed" id="1988429"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 54-1512</scope>
<scope>VARIANTS GLU-308 AND HIS-334</scope>
</reference>
<reference key="5">
<citation type="submission" date="2003-12" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a proliferation inducing gene.</title>
<authorList>
<person name="Kim J.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 62-1512</scope>
<scope>VARIANTS GLU-308 AND HIS-334</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1988" name="Nucleic Acids Res." volume="16" first="5391" last="5406">
<title>The core region of human glutaminyl-tRNA synthetase homologies with the Escherichia coli and yeast enzymes.</title>
<authorList>
<person name="Thoemmes P."/>
<person name="Fett R."/>
<person name="Schray B."/>
<person name="Kunze N."/>
<person name="Knippers R."/>
</authorList>
<dbReference type="PubMed" id="3290852"/>
<dbReference type="DOI" id="10.1093/nar/16.12.5391"/>
</citation>
<scope>PRELIMINARY NUCLEOTIDE SEQUENCE [MRNA] OF 168-959</scope>
<scope>VARIANTS GLU-308 AND HIS-334</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="EMBO J." volume="10" first="4267" last="4277">
<title>A component of the multisynthetase complex is a multifunctional aminoacyl-tRNA synthetase.</title>
<authorList>
<person name="Cerini C."/>
<person name="Kerjan P."/>
<person name="Astier M."/>
<person name="Gratecos D."/>
<person name="Mirande M."/>
<person name="Semeriva M."/>
</authorList>
<dbReference type="PubMed" id="1756734"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1991.tb05005.x"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="J. Mol. Evol." volume="34" first="45" last="53">
<title>Exons encoding the highly conserved part of human glutaminyl-tRNA synthetase.</title>
<authorList>
<person name="Kaiser E."/>
<person name="Eberhard D."/>
<person name="Knippers R."/>
</authorList>
<dbReference type="PubMed" id="1556743"/>
<dbReference type="DOI" id="10.1007/bf00163851"/>
</citation>
<scope>GENE STRUCTURE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Cell Biol." volume="149" first="567" last="574">
<title>Nucleolar localization of human methionyl-tRNA synthetase and its role in ribosomal RNA synthesis.</title>
<authorList>
<person name="Ko Y.G."/>
<person name="Kang Y.S."/>
<person name="Kim E.K."/>
<person name="Park S.G."/>
<person name="Kim S."/>
</authorList>
<dbReference type="PubMed" id="10791971"/>
<dbReference type="DOI" id="10.1083/jcb.149.3.567"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Cell" volume="119" first="195" last="208">
<title>Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation.</title>
<authorList>
<person name="Sampath P."/>
<person name="Mazumder B."/>
<person name="Seshadri V."/>
<person name="Gerber C.A."/>
<person name="Chavatte L."/>
<person name="Kinter M."/>
<person name="Ting S.M."/>
<person name="Dignam J.D."/>
<person name="Kim S."/>
<person name="Driscoll D.M."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="15479637"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.09.030"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE GAIT COMPLEX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="5638" last="5646">
<title>A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis.</title>
<authorList>
<person name="Kato T."/>
<person name="Daigo Y."/>
<person name="Hayama S."/>
<person name="Ishikawa N."/>
<person name="Yamabuki T."/>
<person name="Ito T."/>
<person name="Miyamoto M."/>
<person name="Kondo S."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="15994936"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-0600"/>
</citation>
<scope>INTERACTION WITH DUS2L</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-898</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-872; SER-882; SER-885; SER-886 AND THR-898</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="6053" last="6060">
<title>Dissection of the structural organization of the aminoacyl-tRNA synthetase complex.</title>
<authorList>
<person name="Kaminska M."/>
<person name="Havrylenko S."/>
<person name="Decottignies P."/>
<person name="Gillet S."/>
<person name="Le Marechal P."/>
<person name="Negrutskii B."/>
<person name="Mirande M."/>
</authorList>
<dbReference type="PubMed" id="19131329"/>
<dbReference type="DOI" id="10.1074/jbc.m809636200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="13746" last="13754">
<title>Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells.</title>
<authorList>
<person name="Kaminska M."/>
<person name="Havrylenko S."/>
<person name="Decottignies P."/>
<person name="Le Marechal P."/>
<person name="Negrutskii B."/>
<person name="Mirande M."/>
</authorList>
<dbReference type="PubMed" id="19289464"/>
<dbReference type="DOI" id="10.1074/jbc.m900480200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Mol. Cell" volume="35" first="164" last="180">
<title>Two-site phosphorylation of EPRS coordinates multimodal regulation of noncanonical translational control activity.</title>
<authorList>
<person name="Arif A."/>
<person name="Jia J."/>
<person name="Mukhopadhyay R."/>
<person name="Willard B."/>
<person name="Kinter M."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="19647514"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT SER-886 AND SER-999</scope>
<scope>INTERACTION WITH SYNCRIP</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-882; SER-886 AND SER-891</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-300; LYS-417; LYS-498; LYS-535; LYS-542; LYS-637; LYS-788 AND LYS-1503</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1000</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Mol. Cell. Proteomics" volume="10" first="M111.012658.01" last="M111.012658.12">
<title>The first identification of lysine malonylation substrates and its regulatory enzyme.</title>
<authorList>
<person name="Peng C."/>
<person name="Lu Z."/>
<person name="Xie Z."/>
<person name="Cheng Z."/>
<person name="Chen Y."/>
<person name="Tan M."/>
<person name="Luo H."/>
<person name="Zhang Y."/>
<person name="He W."/>
<person name="Yang K."/>
<person name="Zwaans B.M."/>
<person name="Tishkoff D."/>
<person name="Ho L."/>
<person name="Lombard D."/>
<person name="He T.C."/>
<person name="Dai J."/>
<person name="Verdin E."/>
<person name="Ye Y."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="21908771"/>
<dbReference type="DOI" id="10.1074/mcp.m111.012658"/>
</citation>
<scope>MALONYLATION AT LYS-300</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="1415" last="1420">
<title>Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control.</title>
<authorList>
<person name="Arif A."/>
<person name="Jia J."/>
<person name="Moodt R.A."/>
<person name="DiCorleto P.E."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="21220307"/>
<dbReference type="DOI" id="10.1073/pnas.1011275108"/>
</citation>
<scope>PHOSPHORYLATION AT SER-886</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-886</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="5046" last="5055">
<title>Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages.</title>
<authorList>
<person name="Arif A."/>
<person name="Chatterjee P."/>
<person name="Moodt R.A."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="23071094"/>
<dbReference type="DOI" id="10.1128/mcb.01168-12"/>
</citation>
<scope>FUNCTION</scope>
<scope>RECONSTITUTION OF THE GAIT COMPLEX</scope>
<scope>MUTAGENESIS OF SER-886 AND SER-999</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E81734" last="E81734">
<title>Reinvestigation of aminoacyl-tRNA synthetase core complex by affinity purification-mass spectrometry reveals TARSL2 as a potential member of the complex.</title>
<authorList>
<person name="Kim K."/>
<person name="Park S.J."/>
<person name="Na S."/>
<person name="Kim J.S."/>
<person name="Choi H."/>
<person name="Kim Y.K."/>
<person name="Paek E."/>
<person name="Lee C."/>
</authorList>
<dbReference type="PubMed" id="24312579"/>
<dbReference type="DOI" id="10.1371/journal.pone.0081734"/>
</citation>
<scope>IDENTIFICATION IN THE MSC COMPLEX</scope>
<scope>INTERACTION WITH TARS3</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-355; SER-434; SER-747; SER-882; SER-886; THR-898; SER-998 AND SER-1350</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1152</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2017" name="Nature" volume="542" first="357" last="361">
<title>EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice.</title>
<authorList>
<person name="Arif A."/>
<person name="Terenzi F."/>
<person name="Potdar A.A."/>
<person name="Jia J."/>
<person name="Sacks J."/>
<person name="China A."/>
<person name="Halawani D."/>
<person name="Vasu K."/>
<person name="Li X."/>
<person name="Brown J.M."/>
<person name="Chen J."/>
<person name="Kozma S.C."/>
<person name="Thomas G."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="28178239"/>
<dbReference type="DOI" id="10.1038/nature21380"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SLC27A1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
<scope>PHOSPHORYLATION AT SER-999 BY RPS6KB1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2018" name="Am. J. Hum. Genet." volume="102" first="676" last="684">
<title>Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy.</title>
<authorList>
<person name="Mendes M.I."/>
<person name="Gutierrez Salazar M."/>
<person name="Guerrero K."/>
<person name="Thiffault I."/>
<person name="Salomons G.S."/>
<person name="Gauquelin L."/>
<person name="Tran L.T."/>
<person name="Forget D."/>
<person name="Gauthier M.S."/>
<person name="Waisfisz Q."/>
<person name="Smith D.E.C."/>
<person name="Simons C."/>
<person name="van der Knaap M.S."/>
<person name="Marquardt I."/>
<person name="Lemes A."/>
<person name="Mierzewska H."/>
<person name="Weschke B."/>
<person name="Koehler W."/>
<person name="Coulombe B."/>
<person name="Wolf N.I."/>
<person name="Bernard G."/>
</authorList>
<dbReference type="PubMed" id="29576217"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2018.02.011"/>
</citation>
<scope>INVOLVEMENT IN HLD15</scope>
<scope>VARIANTS HLD15 339-ARG--TYR-1512 DEL; ARG-1115; THR-1126 AND SER-1160</scope>
<scope>CHARACTERIZATION OF VARIANTS HLD15 ARG-1115 AND THR-1126</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2000" name="Biochemistry" volume="39" first="15775" last="15782">
<title>Structural analysis of multifunctional peptide motifs in human bifunctional tRNA synthetase: identification of RNA-binding residues and functional implications for tandem repeats.</title>
<authorList>
<person name="Jeong E.-J."/>
<person name="Hwang G.-S."/>
<person name="Kim K.H."/>
<person name="Kim M.J."/>
<person name="Kim S."/>
<person name="Kim K.-S."/>
</authorList>
<dbReference type="PubMed" id="11123902"/>
<dbReference type="DOI" id="10.1021/bi001393h"/>
</citation>
<scope>STRUCTURE BY NMR OF 749-805</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="38" evidence="3 4 5">
<citation type="journal article" date="2013" name="Acta Crystallogr. D" volume="69" first="2136" last="2145">
<title>Conformational changes in human prolyl-tRNA synthetase upon binding of the substrates proline and ATP and the inhibitor halofuginone.</title>
<authorList>
<person name="Son J."/>
<person name="Lee E.H."/>
<person name="Park M."/>
<person name="Kim J.H."/>
<person name="Kim J."/>
<person name="Kim S."/>
<person name="Jeon Y.H."/>
<person name="Hwang K.Y."/>
</authorList>
<dbReference type="PubMed" id="24100331"/>
<dbReference type="DOI" id="10.1107/s0907444913020556"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1000-1512 IN COMPLEXES WITH SYNTHETIC INHIBITOR HALOFUGINONE; L-PROLINE; ZINC AND ADENOSINE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF PHE-1097 AND ARG-1152</scope>
</reference>
<reference key="39" evidence="2">
<citation type="journal article" date="2013" name="Nature" volume="494" first="121" last="124">
<title>ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase.</title>
<authorList>
<person name="Zhou H."/>
<person name="Sun L."/>
<person name="Yang X.L."/>
<person name="Schimmel P."/>
</authorList>
<dbReference type="PubMed" id="23263184"/>
<dbReference type="DOI" id="10.1038/nature11774"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1003-1512 IN COMPLEX WITH SYNTHETIC INHIBITOR; ZINC AND ATP ANALOG</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="40" evidence="7 8">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="29313" last="29328">
<title>Assembly of Multi-tRNA Synthetase Complex via Heterotetrameric Glutathione Transferase-homology Domains.</title>
<authorList>
<person name="Cho H.Y."/>
<person name="Maeng S.J."/>
<person name="Cho H.J."/>
<person name="Choi Y.S."/>
<person name="Chung J.M."/>
<person name="Lee S."/>
<person name="Kim H.K."/>
<person name="Kim J.H."/>
<person name="Eom C.Y."/>
<person name="Kim Y.G."/>
<person name="Guo M."/>
<person name="Jung H.S."/>
<person name="Kang B.S."/>
<person name="Kim S."/>
</authorList>
<dbReference type="PubMed" id="26472928"/>
<dbReference type="DOI" id="10.1074/jbc.m115.690867"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-175</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="23 26 34 35 36 39">Multifunctional protein which is primarily part of the aminoacyl-tRNA synthetase multienzyme complex, also know as multisynthetase complex, that catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA (PubMed:1756734, PubMed:24100331, PubMed:23263184). The phosphorylation of EPRS1, induced by interferon-gamma, dissociates the protein from the aminoacyl-tRNA synthetase multienzyme complex and recruits it to the GAIT complex that binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin), suppressing their translation. Interferon-gamma can therefore redirect, in specific cells, the EPRS1 function from protein synthesis to translation inhibition (PubMed:15479637, PubMed:23071094). Also functions as an effector of the mTORC1 signaling pathway by promoting, through SLC27A1, the uptake of long-chain fatty acid by adipocytes. Thereby, it also plays a role in fat metabolism and more indirectly influences lifespan (PubMed:28178239).</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>ATP + L-glutamate + tRNA(Glu) = AMP + diphosphate + L-glutamyl-tRNA(Glu)</text>
<dbReference type="Rhea" id="RHEA:23540"/>
<dbReference type="Rhea" id="RHEA-COMP:9663"/>
<dbReference type="Rhea" id="RHEA-COMP:9680"/>
<dbReference type="ChEBI" id="CHEBI:29985"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:78442"/>
<dbReference type="ChEBI" id="CHEBI:78520"/>
<dbReference type="ChEBI" id="CHEBI:456215"/>
<dbReference type="EC" id="6.1.1.17"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="35 36">
<text>ATP + L-proline + tRNA(Pro) = AMP + diphosphate + L-prolyl-tRNA(Pro)</text>
<dbReference type="Rhea" id="RHEA:14305"/>
<dbReference type="Rhea" id="RHEA-COMP:9700"/>
<dbReference type="Rhea" id="RHEA-COMP:9702"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:60039"/>
<dbReference type="ChEBI" id="CHEBI:78442"/>
<dbReference type="ChEBI" id="CHEBI:78532"/>
<dbReference type="ChEBI" id="CHEBI:456215"/>
<dbReference type="EC" id="6.1.1.15"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="35 36">Inhibited by halofuginone.</text>
</comment>
<comment type="subunit">
<text evidence="23 25 28 29 30 35 36 37 38 39">Homodimer (PubMed:24100331, PubMed:23263184). Part of the aminoacyl-tRNA synthetase multienzyme complex, also know as multisynthetase complex (MSC), that is composed of the tRNA ligases for Arg (RARS1), Asp (DARS1), Gln (QARS1), Ile (IARS1), Leu (LARS1), Lys (KARS1), Met (MARS1) the bifunctional ligase for Glu and Pro (EPRS1) and the auxiliary subunits AIMP1/p43, AIMP2/p38 and EEF1E1/p18 (PubMed:24312579, PubMed:19131329, PubMed:19289464). Forms a linear complex that contains MARS1, EEF1E1, EPRS1 and AIMP2 that is at the core of the multisubunit complex (PubMed:26472928). Interacts with TARS3 (PubMed:24312579). Interacts with DUS2L (PubMed:15994936). Component of the GAIT complex which is composed of EPRS1, RPL13A and GAPDH. For human, the complex assembly seems to be a two-step process in which EPRS1 first associates with SYNCRIP to form a pre-GAIT complex which is deficient in GAIT element binding (PubMed:15479637). Interacts (phosphorylated at Ser-999) with SLC27A1; mediates the translocation of SLC27A1 from the cytoplasm to the plasma membrane thereby increasing the uptake of long-chain fatty acids (PubMed:28178239).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355315">
<id>P07814</id>
</interactant>
<interactant intactId="EBI-355315">
<id>P07814</id>
<label>EPRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355315">
<id>P07814</id>
</interactant>
<interactant intactId="EBI-1805738">
<id>Q8IWL3</id>
<label>HSCB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355315">
<id>P07814</id>
</interactant>
<interactant intactId="EBI-355303">
<id>P41252</id>
<label>IARS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355315">
<id>P07814</id>
</interactant>
<interactant intactId="EBI-356367">
<id>Q15046</id>
<label>KARS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355315">
<id>P07814</id>
</interactant>
<interactant intactId="EBI-1024357">
<id>O60506</id>
<label>SYNCRIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 29">Cytoplasm</location>
<location evidence="22 29">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="39">Membrane</location>
<topology evidence="44 45">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="29 39">Translocates from cytosol to membranes upon phosphorylation at Ser-999.</text>
</comment>
<comment type="domain">
<text evidence="19">The WHEP-TRS domains are involved in RNA binding.</text>
</comment>
<comment type="PTM">
<text evidence="30 32 39">Phosphorylated at Ser-886 by CDK5 (PubMed:19647514, PubMed:21220307). Phosphorylated at Ser-999 by RPS6KB1; triggers EPRS1 release from the aminoacyl-tRNA synthetase multienzyme complex (PubMed:19647514, PubMed:21220307, PubMed:28178239). In monocytes, the IFN-gamma-induced sequential phosphorylation at Ser-886 and Ser-999 releases EPRS1 from the aminoacyl-tRNA synthetase multienzyme complex, allowing its association with the GAIT complex. Phosphorylation at Ser-999 is specifically required for the RPL13A-mediated interaction of the GAIT complex with eIF4G (PubMed:19647514, PubMed:21220307). Phosphorylation at Ser-999 by RPS6KB1, is also induced by insulin through activation of the mTORC1 signaling pathway and promotes the interaction of EPRS1 with SLC27A1 (PubMed:28178239).</text>
</comment>
<comment type="disease" evidence="40">
<disease id="DI-05239">
<name>Leukodystrophy, hypomyelinating, 15</name>
<acronym>HLD15</acronym>
<description>An autosomal recessive disorder characterized by hypomyelinating leukodystrophy with thinning of the corpus callosum. Clinical features include motor and cognitive impairment appearing in the first or second decade of life, dystonia, ataxia, spasticity, and dysphagia. Most patients develop severe optic atrophy, and some have hearing loss.</description>
<dbReference type="MIM" id="617951"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="43">In the N-terminal section; belongs to the class-I aminoacyl-tRNA synthetase family. Glutamate--tRNA ligase type 2 subfamily.</text>
</comment>
<comment type="similarity">
<text evidence="43">In the C-terminal section; belongs to the class-II aminoacyl-tRNA synthetase family.</text>
</comment>
<comment type="caution">
<text evidence="43">Was originally thought to be a glutaminyl-tRNA synthetase.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH15494" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH34797" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH46156" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH58921" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAS72877" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAA30354" version="1"/>
</conflict>
<text>Sequencing errors.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA38224" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EC" id="6.1.1.17"/>
<dbReference type="EC" id="6.1.1.15" evidence="35 36"/>
<dbReference type="EMBL" id="CR933648">
<property type="protein sequence ID" value="CAI45949.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC103590">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015494">
<property type="protein sequence ID" value="AAH15494.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC034797">
<property type="protein sequence ID" value="AAH34797.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC046156">
<property type="protein sequence ID" value="AAH46156.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC058921">
<property type="protein sequence ID" value="AAH58921.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126275">
<property type="protein sequence ID" value="AAI26276.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136465">
<property type="protein sequence ID" value="AAI36466.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X54326">
<property type="protein sequence ID" value="CAA38224.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY493416">
<property type="protein sequence ID" value="AAS72877.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X07466">
<property type="protein sequence ID" value="CAA30354.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31027.1"/>
<dbReference type="PIR" id="A38663">
<property type="entry name" value="SYHUQT"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004437.2">
<property type="nucleotide sequence ID" value="NM_004446.2"/>
</dbReference>
<dbReference type="PDB" id="1FYJ">
<property type="method" value="NMR"/>
<property type="chains" value="A=749-805"/>
</dbReference>
<dbReference type="PDB" id="4HVC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1003-1512"/>
</dbReference>
<dbReference type="PDB" id="4K86">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1000-1512"/>
</dbReference>
<dbReference type="PDB" id="4K87">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1000-1512"/>
</dbReference>
<dbReference type="PDB" id="4K88">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A=1000-1512"/>
</dbReference>
<dbReference type="PDB" id="5A1N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-175"/>
</dbReference>
<dbReference type="PDB" id="5A34">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C/E/G=1-175"/>
</dbReference>
<dbReference type="PDB" id="5A5H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.32"/>
<property type="chains" value="A/C/E/G=1-175"/>
</dbReference>
<dbReference type="PDB" id="5BMU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B/D/F/H=1-175"/>
</dbReference>
<dbReference type="PDB" id="5V58">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="A=1003-1512"/>
</dbReference>
<dbReference type="PDB" id="5VAD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.36"/>
<property type="chains" value="A/B=998-1512"/>
</dbReference>
<dbReference type="PDB" id="5Y6L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="C=1-175"/>
</dbReference>
<dbReference type="PDB" id="6IY6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="E/F/K/L=1-157"/>
</dbReference>
<dbReference type="PDBsum" id="1FYJ"/>
<dbReference type="PDBsum" id="4HVC"/>
<dbReference type="PDBsum" id="4K86"/>
<dbReference type="PDBsum" id="4K87"/>
<dbReference type="PDBsum" id="4K88"/>
<dbReference type="PDBsum" id="5A1N"/>
<dbReference type="PDBsum" id="5A34"/>
<dbReference type="PDBsum" id="5A5H"/>
<dbReference type="PDBsum" id="5BMU"/>
<dbReference type="PDBsum" id="5V58"/>
<dbReference type="PDBsum" id="5VAD"/>
<dbReference type="PDBsum" id="5Y6L"/>
<dbReference type="PDBsum" id="6IY6"/>
<dbReference type="SMR" id="P07814"/>
<dbReference type="BioGRID" id="108372">
<property type="interactions" value="262"/>
</dbReference>
<dbReference type="CORUM" id="P07814"/>
<dbReference type="DIP" id="DIP-40825N"/>
<dbReference type="IntAct" id="P07814">
<property type="interactions" value="64"/>
</dbReference>
<dbReference type="MINT" id="P07814"/>
<dbReference type="STRING" id="9606.ENSP00000355890"/>
<dbReference type="BindingDB" id="P07814"/>
<dbReference type="ChEMBL" id="CHEMBL3873"/>
<dbReference type="DrugBank" id="DB02684">
<property type="generic name" value="5'-O-(L-Cysteinylsulfamoyl)adenosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB02510">
<property type="generic name" value="5'-O-(L-Prolylsulfamoyl)adenosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB03376">
<property type="generic name" value="5'-O-(N-(Alanyl)sulfamoyl)adenosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00142">
<property type="generic name" value="Glutamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00172">
<property type="generic name" value="Proline"/>
</dbReference>
<dbReference type="MoonProt" id="P07814"/>
<dbReference type="GlyGen" id="P07814">
<property type="glycosylation" value="2 sites, 1 O-linked glycan (2 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P07814"/>
<dbReference type="MetOSite" id="P07814"/>
<dbReference type="PhosphoSitePlus" id="P07814"/>
<dbReference type="SwissPalm" id="P07814"/>
<dbReference type="BioMuta" id="EPRS"/>
<dbReference type="DMDM" id="288558855"/>
<dbReference type="CPTAC" id="CPTAC-71"/>
<dbReference type="CPTAC" id="CPTAC-72"/>
<dbReference type="EPD" id="P07814"/>
<dbReference type="jPOST" id="P07814"/>
<dbReference type="MassIVE" id="P07814"/>
<dbReference type="MaxQB" id="P07814"/>
<dbReference type="PaxDb" id="P07814"/>
<dbReference type="PeptideAtlas" id="P07814"/>
<dbReference type="PRIDE" id="P07814"/>
<dbReference type="ProteomicsDB" id="52028"/>
<dbReference type="Antibodypedia" id="20734">
<property type="antibodies" value="178 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366923">
<property type="protein sequence ID" value="ENSP00000355890"/>
<property type="gene ID" value="ENSG00000136628"/>
</dbReference>
<dbReference type="GeneID" id="2058"/>
<dbReference type="KEGG" id="hsa:2058"/>
<dbReference type="UCSC" id="uc001hly.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2058"/>
<dbReference type="DisGeNET" id="2058"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136628.17"/>
<dbReference type="GeneCards" id="EPRS1"/>
<dbReference type="HGNC" id="HGNC:3418">
<property type="gene designation" value="EPRS1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136628">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="EPRS1"/>
<dbReference type="MIM" id="138295">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617951">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P07814"/>
<dbReference type="OpenTargets" id="ENSG00000136628"/>
<dbReference type="PharmGKB" id="PA27837"/>
<dbReference type="eggNOG" id="KOG1147">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="KOG4163">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074815"/>
<dbReference type="HOGENOM" id="CLU_001882_0_2_1"/>
<dbReference type="InParanoid" id="P07814"/>
<dbReference type="KO" id="K14163"/>
<dbReference type="OMA" id="WDPKGNN"/>
<dbReference type="OrthoDB" id="809861at2759"/>
<dbReference type="PhylomeDB" id="P07814"/>
<dbReference type="TreeFam" id="TF300380"/>
<dbReference type="BRENDA" id="6.1.1.15">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P07814"/>
<dbReference type="Reactome" id="R-HSA-2408522">
<property type="pathway name" value="Selenoamino acid metabolism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-379716">
<property type="pathway name" value="Cytosolic tRNA aminoacylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782315">
<property type="pathway name" value="tRNA modification in the nucleus and cytosol"/>
</dbReference>
<dbReference type="SIGNOR" id="P07814"/>
<dbReference type="BioGRID-ORCS" id="2058">
<property type="hits" value="727 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="EPRS">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P07814"/>
<dbReference type="GeneWiki" id="EPRS"/>
<dbReference type="GenomeRNAi" id="2058"/>
<dbReference type="Pharos" id="P07814">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P07814"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P07814">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136628">
<property type="expression patterns" value="Expressed in parotid gland and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P07814">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P07814">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0017101">
<property type="term" value="C:aminoacyl-tRNA synthetase multienzyme complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097452">
<property type="term" value="C:GAIT complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004818">
<property type="term" value="F:glutamate-tRNA ligase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051020">
<property type="term" value="F:GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004827">
<property type="term" value="F:proline-tRNA ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035613">
<property type="term" value="F:RNA stem-loop binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006424">
<property type="term" value="P:glutamyl-tRNA aminoacylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006433">
<property type="term" value="P:prolyl-tRNA aminoacylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0065003">
<property type="term" value="P:protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0140212">
<property type="term" value="P:regulation of long-chain fatty acid import into cell"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006418">
<property type="term" value="P:tRNA aminoacylation for protein translation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00778">
<property type="entry name" value="ProRS_core_arch_euk"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.40.240.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.110.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.620">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.800">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_02076">
<property type="entry name" value="Glu_tRNA_synth_type2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_01571">
<property type="entry name" value="Pro_tRNA_synth_type3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002314">
<property type="entry name" value="aa-tRNA-synt_IIb"/>
</dbReference>
<dbReference type="InterPro" id="IPR001412">
<property type="entry name" value="aa-tRNA-synth_I_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR006195">
<property type="entry name" value="aa-tRNA-synth_II"/>
</dbReference>
<dbReference type="InterPro" id="IPR004154">
<property type="entry name" value="Anticodon-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036621">
<property type="entry name" value="Anticodon-bd_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR004526">
<property type="entry name" value="Glu-tRNA-synth_arc/euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR000924">
<property type="entry name" value="Glu/Gln-tRNA-synth"/>
</dbReference>
<dbReference type="InterPro" id="IPR020058">
<property type="entry name" value="Glu/Gln-tRNA-synth_Ib_cat-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR020059">
<property type="entry name" value="Glu/Gln-tRNA-synth_Ib_codon-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036282">
<property type="entry name" value="Glutathione-S-Trfase_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR004046">
<property type="entry name" value="GST_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR004499">
<property type="entry name" value="Pro-tRNA-ligase_IIa_arc-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR016061">
<property type="entry name" value="Pro-tRNA_ligase_II_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR017449">
<property type="entry name" value="Pro-tRNA_synth_II"/>
</dbReference>
<dbReference type="InterPro" id="IPR033721">
<property type="entry name" value="ProRS_core_arch_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR020056">
<property type="entry name" value="Rbsml_L25/Gln-tRNA_synth_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR011035">
<property type="entry name" value="Ribosomal_L25/Gln-tRNA_synth"/>
</dbReference>
<dbReference type="InterPro" id="IPR014729">
<property type="entry name" value="Rossmann-like_a/b/a_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR009068">
<property type="entry name" value="S15_NS1_RNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000738">
<property type="entry name" value="WHEP-TRS_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00043">
<property type="entry name" value="GST_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03129">
<property type="entry name" value="HGTP_anticodon"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09180">
<property type="entry name" value="ProRS-C_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00749">
<property type="entry name" value="tRNA-synt_1c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03950">
<property type="entry name" value="tRNA-synt_1c_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00587">
<property type="entry name" value="tRNA-synt_2b"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00458">
<property type="entry name" value="WHEP-TRS"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PRINTS" id="PR00987">
<property type="entry name" value="TRNASYNTHGLU"/>
</dbReference>
<dbReference type="SMART" id="SM00946">
<property type="entry name" value="ProRS-C_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00991">
<property type="entry name" value="WHEP-TRS"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47060">
<property type="entry name" value="SSF47060"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47616">
<property type="entry name" value="SSF47616"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50715">
<property type="entry name" value="SSF50715"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF64586">
<property type="entry name" value="SSF64586"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00463">
<property type="entry name" value="gltX_arch"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00408">
<property type="entry name" value="proS_fam_I"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00178">
<property type="entry name" value="AA_TRNA_LIGASE_I"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50862">
<property type="entry name" value="AA_TRNA_LIGASE_II"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00762">
<property type="entry name" value="WHEP_TRS_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS51185">
<property type="entry name" value="WHEP_TRS_2"/>
<property type="match status" value="3"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0030">Aminoacyl-tRNA synthetase</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1026">Leukodystrophy</keyword>
<keyword id="KW-0436">Ligase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0511">Multifunctional enzyme</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0648">Protein biosynthesis</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Bifunctional glutamate/proline--tRNA ligase" id="PRO_0000119743">
<location>
<begin position="1"/>
<end position="1512"/>
</location>
</feature>
<feature type="domain" description="WHEP-TRS 1">
<location>
<begin position="749"/>
<end position="805"/>
</location>
</feature>
<feature type="domain" description="WHEP-TRS 2">
<location>
<begin position="822"/>
<end position="878"/>
</location>
</feature>
<feature type="domain" description="WHEP-TRS 3">
<location>
<begin position="900"/>
<end position="956"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="18">
<location>
<begin position="432"/>
<end position="436"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2 4 35 36">
<location>
<begin position="1152"/>
<end position="1154"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2 4 35 36">
<location>
<begin position="1163"/>
<end position="1164"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2 4 35 36">
<location>
<begin position="1237"/>
<end position="1240"/>
</location>
</feature>
<feature type="region of interest" description="Glutamate--tRNA ligase">
<location>
<begin position="164"/>
<end position="759"/>
</location>
</feature>
<feature type="region of interest" description="3 X 57 AA approximate repeats">
<location>
<begin position="760"/>
<end position="956"/>
</location>
</feature>
<feature type="region of interest" description="Charged">
<location>
<begin position="959"/>
<end position="991"/>
</location>
</feature>
<feature type="region of interest" description="Proline--tRNA ligase">
<location>
<begin position="1007"/>
<end position="1512"/>
</location>
</feature>
<feature type="region of interest" description="L-proline binding" evidence="4 36">
<location>
<begin position="1121"/>
<end position="1123"/>
</location>
</feature>
<feature type="short sequence motif" description="'HIGH' region">
<location>
<begin position="204"/>
<end position="214"/>
</location>
</feature>
<feature type="short sequence motif" description="'KMSKS' region">
<location>
<begin position="432"/>
<end position="436"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich" evidence="21">
<location>
<begin position="961"/>
<end position="991"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 4 35 36">
<location>
<position position="1448"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 4 5 35 36">
<location>
<position position="1453"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 4 5 35 36">
<location>
<position position="1495"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 3 4 5 35 36">
<location>
<position position="1497"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="18">
<location>
<position position="211"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="18">
<location>
<position position="398"/>
</location>
</feature>
<feature type="binding site" description="L-proline" evidence="4 36">
<location>
<position position="1152"/>
</location>
</feature>
<feature type="binding site" description="L-proline" evidence="4 36">
<location>
<position position="1242"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="2 4 35 36">
<location>
<position position="1276"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12">
<location>
<position position="300"/>
</location>
</feature>
<feature type="modified residue" description="N6-malonyllysine; alternate" evidence="33">
<location>
<position position="300"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="417"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="498"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="535"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="542"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="637"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="747"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="788"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="20">
<location>
<position position="861"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="872"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 16">
<location>
<position position="882"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="885"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="11 13 15 16 30 32">
<location>
<position position="886"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="891"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 11 16">
<location>
<position position="898"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="998"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KB1" evidence="30 39">
<location>
<position position="999"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1000"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="17">
<location>
<position position="1152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="1350"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="1503"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35999099." id="VAR_037288">
<original>A</original>
<variation>P</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230301." id="VAR_037289" evidence="24 27 31 41 42">
<original>D</original>
<variation>E</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1063236." id="VAR_037290" evidence="31 41 42">
<original>Q</original>
<variation>H</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In HLD15." id="VAR_080800" evidence="40">
<location>
<begin position="339"/>
<end position="1512"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030751." id="VAR_037291">
<original>P</original>
<variation>H</variation>
<location>
<position position="893"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230302." id="VAR_057358">
<original>E</original>
<variation>G</variation>
<location>
<position position="913"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030752." id="VAR_037292" evidence="27">
<original>I</original>
<variation>V</variation>
<location>
<position position="1043"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12144752." id="VAR_037293">
<original>S</original>
<variation>F</variation>
<location>
<position position="1107"/>
</location>
</feature>
<feature type="sequence variant" description="In HLD15; slightly decreased protein level; does not affect multisynthetase complex assembly; dbSNP:rs1288116010." id="VAR_080801" evidence="40">
<original>P</original>
<variation>R</variation>
<location>
<position position="1115"/>
</location>
</feature>
<feature type="sequence variant" description="In HLD15; unknown pathological significance; small decrease in aminoacylation activity; dbSNP:rs1474000585." id="VAR_080802" evidence="40">
<original>M</original>
<variation>T</variation>
<location>
<position position="1126"/>
</location>
</feature>
<feature type="sequence variant" description="In HLD15; unknown pathological significance; dbSNP:rs898824971." id="VAR_080803" evidence="40">
<original>P</original>
<variation>S</variation>
<location>
<position position="1160"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34559775." id="VAR_037294">
<original>T</original>
<variation>N</variation>
<location>
<position position="1399"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes release from the aminoacyl-tRNA synthetase multienzyme complex and association with the GAIT complex upon interferon-gamma treatment. Abolishes interaction with SYNCRIP." evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="886"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not active in translation inhibition (phosphomimetic) and abolishes GAIT complex association with eiF4G. No effect on interaction with SYNCRIP." evidence="34">
<original>S</original>
<variation>D</variation>
<location>
<position position="886"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not active in translation inhibition, abolishes release from the aminoacyl-tRNA synthetase multienzyme complex and association with the GAIT complex upon interferon-gamma treatment." evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="999"/>
</location>
</feature>
<feature type="mutagenesis site" description="Active in translation inhibition (phosphomimetic). No effect on GAIT complex association with eiF4G." evidence="34">
<original>S</original>
<variation>D</variation>
<location>
<position position="999"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost complete loss of prolyl-tRNA ligase activity." evidence="36">
<original>F</original>
<variation>A</variation>
<location>
<position position="1097"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on prolyl-tRNA ligase activity. Decreases inhibition by halofuginone." evidence="36">
<original>F</original>
<variation>W</variation>
<location>
<position position="1097"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on prolyl-tRNA ligase activity. Decreases inhibition by halofuginone." evidence="36">
<original>R</original>
<variation>K</variation>
<location>
<position position="1152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost complete loss of prolyl-tRNA ligase activity." evidence="36">
<original>R</original>
<variation>L</variation>
<location>
<position position="1152"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAI45949." ref="1" evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA38224 and 5; AAS72877." ref="4 5" evidence="43">
<original>L</original>
<variation>F</variation>
<location>
<position position="594"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAI45949." ref="1" evidence="43">
<original>K</original>
<variation>E</variation>
<location>
<position position="943"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAI45949." ref="1" evidence="43">
<original>ATM</original>
<variation>VTV</variation>
<location>
<begin position="1177"/>
<end position="1179"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAI45949." ref="1" evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1441"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="4"/>
<end position="7"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="10"/>
<end position="12"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="15"/>
<end position="24"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="30"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="39"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="46"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="51"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="72"/>
<end position="87"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="95"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="110"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="114"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="119"/>
<end position="129"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="132"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="145"/>
<end position="155"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="158"/>
<end position="167"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="750"/>
<end position="769"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="774"/>
<end position="795"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1020"/>
<end position="1022"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1024"/>
<end position="1034"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1038"/>
<end position="1040"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1042"/>
<end position="1045"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1047"/>
<end position="1049"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1051"/>
<end position="1070"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1080"/>
<end position="1083"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1084"/>
<end position="1087"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1088"/>
<end position="1090"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1095"/>
<end position="1100"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1102"/>
<end position="1107"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1110"/>
<end position="1118"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1120"/>
<end position="1122"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1123"/>
<end position="1133"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1137"/>
<end position="1139"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1142"/>
<end position="1151"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1160"/>
<end position="1162"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1165"/>
<end position="1178"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1179"/>
<end position="1198"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1206"/>
<end position="1209"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1212"/>
<end position="1214"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1219"/>
<end position="1229"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1230"/>
<end position="1233"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1234"/>
<end position="1245"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1247"/>
<end position="1252"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1255"/>
<end position="1257"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1259"/>
<end position="1261"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1265"/>
<end position="1267"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1269"/>
<end position="1276"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1278"/>
<end position="1287"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1297"/>
<end position="1299"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1303"/>
<end position="1308"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1313"/>
<end position="1315"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1317"/>
<end position="1336"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1341"/>
<end position="1343"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1347"/>
<end position="1349"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1351"/>
<end position="1360"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1364"/>
<end position="1369"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1371"/>
<end position="1376"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1378"/>
<end position="1383"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1384"/>
<end position="1386"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1389"/>
<end position="1393"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1394"/>
<end position="1396"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1397"/>
<end position="1423"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1424"/>
<end position="1426"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1430"/>
<end position="1438"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1442"/>
<end position="1447"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1451"/>
<end position="1462"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1477"/>
<end position="1484"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1498"/>
<end position="1501"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1504"/>
<end position="1509"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FYJ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HVC"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K86"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K87"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K88"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5A1N"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5A34"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5BMU"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5VAD"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250"/>
<evidence key="19" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q7SIA2"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8CGC7"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00012"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10791971"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15479637"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15994936"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1756734"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19131329"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19289464"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19647514"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1988429"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21220307"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21908771"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23071094"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23263184"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24100331"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24312579"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26472928"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28178239"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29576217"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3290852"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<evidence key="44" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19289464"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="28178239"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:3418"/>
</source>
</evidence>
<sequence length="1512" mass="170591" checksum="2CE4311076719403" modified="2010-02-09" version="5">MATLSLTVNSGDPPLGALLAVEHVKDDVSISVEEGKENILHVSENVIFTDVNSILRYLARVATTAGLYGSNLMEHTEIDHWLEFSATKLSSCDSFTSTINELNHCLSLRTYLVGNSLSLADLCVWATLKGNAAWQEQLKQKKAPVHVKRWFGFLEAQQAFQSVGTKWDVSTTKARVAPEKKQDVGKFVELPGAEMGKVTVRFPPEASGYLHIGHAKAALLNQHYQVNFKGKLIMRFDDTNPEKEKEDFEKVILEDVAMLHIKPDQFTYTSDHFETIMKYAEKLIQEGKAYVDDTPAEQMKAEREQRIDSKHRKNPIEKNLQMWEEMKKGSQFGQSCCLRAKIDMSSNNGCMRDPTLYRCKIQPHPRTGNKYNVYPTYDFACPIVDSIEGVTHALRTTEYHDRDEQFYWIIEALGIRKPYIWEYSRLNLNNTVLSKRKLTWFVNEGLVDGWDDPRFPTVRGVLRRGMTVEGLKQFIAAQGSSRSVVNMEWDKIWAFNKKVIDPVAPRYVALLKKEVIPVNVPEAQEEMKEVAKHPKNPEVGLKPVWYSPKVFIEGADAETFSEGEMVTFINWGNLNITKIHKNADGKIISLDAKLNLENKDYKKTTKVTWLAETTHALPIPVICVTYEHLITKPVLGKDEDFKQYVNKNSKHEELMLGDPCLKDLKKGDIIQLQRRGFFICDQPYEPVSPYSCKEAPCVLIYIPDGHTKEMPTSGSKEKTKVEATKNETSAPFKERPTPSLNNNCTTSEDSLVLYNRVAVQGDVVRELKAKKAPKEDVDAAVKQLLSLKAEYKEKTGQEYKPGNPPAEIGQNISSNSSASILESKSLYDEVAAQGEVVRKLKAEKSPKAKINEAVECLLSLKAQYKEKTGKEYIPGQPPLSQSSDSSPTRNSEPAGLETPEAKVLFDKVASQGEVVRKLKTEKAPKDQVDIAVQELLQLKAQYKSLIGVEYKPVSATGAEDKDKKKKEKENKSEKQNKPQKQNDGQRKDPSKNQGGGLSSSGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

